General Information of the Compound
Compound ID
CP0385621
Compound Name
US9187480, N-{1-[8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl]piperidin-4-yl}pentanamide
    Show/Hide
Synonyms
Diphenyl purine derivative 5
PMID26161824-Compound-154
    Show/Hide
Structure
Formula
C27H28Cl2N6O
Molecular Weight
523.468
Canonical SMILES
CCCCC(=O)NC1CCN(CC1)c1ncnc2n(c(nc12)-c1ccccc1Cl)-c1ccc(Cl)cc1
    Show/Hide
InChI
InChI=1S/C27H28Cl2N6O/c1-2-3-8-23(36)32-19-13-15-34(16-14-19)26-24-27(31-17-30-26)35(20-11-9-18(28)10-12-20)25(33-24)21-6-4-5-7-22(21)29/h4-7,9-12,17,19H,2-3,8,13-16H2,1H3,(H,32,36)
    Show/Hide
InChIKey
JSIOAJBHLWGADL-UHFFFAOYSA-N
Physicochemical Property
logP
6.0645
Rotatable Bonds
7
Heavy Atom Count
36
Polar Areas
75.94
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
36

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 72713196
ChEMBL ID
CHEMBL2436757
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01298, Cannabinoid receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000026 CHO-K1 Cricetulus griseus (Chinese hamster)  1
1
Ki = 19.47 nM
   TI
   LI
   LO
   TS
Protein ID: PT00834, Cannabinoid receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000026 CHO-K1 Cricetulus griseus (Chinese hamster)  1
1
Ki = 1046 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Diphenyl purine derivative 5 )
Drug Name Diphenyl purine derivative 5
Company RESEARCH TRIANGLE INSTITUTE
Indication
Obesity
Patented
Target(s)
Cannabinoid receptor 1 (CB1)
Antagonist